Delivery Order SPE2DB22D2103-SPE2DB25FR9TZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,700.49 to AmerisourceBergen Drug Corp for the supply of Plaquenil 200 mg tablets in quantities of 100 units. The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, operates under firm fixed pricing with no set-aside designation, indicating open and competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.40 firm-fixed-price contract is for the delivery of Plaquenil 200 mg tablets. The contract has a completion date of March 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $318.24 to supply 100 tablets of Plaquenil 200 mg. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by August 25, 2023 under the terms of the contract. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $199.02 firm fixed price delivery order contract to supply 4561475224 PLAQUENIL 200 MG TABLET 100S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the one day period of July 12-13, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to support the...
- The Defense Logistics Agency awarded a $320,580 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of Plaquenil 200 mg tablets. As one of the largest medical/surgical prime vendors for the Department of Defense, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to an unknown customer by August 1, 2023 under contract number 4561652713. The order was placed utilizing the Medical/Surgical Prime...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $548 to supply 100 tablets of the drug Plaquenil. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in July 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver this order of the malaria drug to support the Agency's stockpile needs. No subcontractors or set...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,711.53 firm fixed-price contract is for the delivery of 100 tablets of the drug Plaquenil (hydroxychloroquine sulfate 200 mg) to Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00...
- The Defense Logistics Agency Troop Support Medical awarded a $132,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg tablets of hydroxychloroquine sulfate, also known as Plaquenil. Amerisourcebergen will deliver 100 tablets under the contract, which runs from September 1-5, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,378.32 firm fixed-price contract is for the delivery of Plaquenil 200 mg tablets, a medication used to treat malaria, lupus, and rheumatoid arthritis. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9TZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Plaquenil 200 mg tablets (100-count units) with a contract value of $1,318.08. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company competitively won this delivery order based on its established capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains. This specific order for Plaquenil, an antimalarial medication commonly used in military medical supply chains, exemplifies the routine pharmaceutical procurement activities conducted through the DLA's prime vendor program, which streamlines the supply chain for Defense Health Agency and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/10/25 |